Skip to Main Navigation
Skip to Page Content
Share This:

Funding Opportunities for Test Method Developers

NICEATM and ICCVAM seek to facilitate development of test methods that replace, reduce, and refine the use of animals in testing. In addition, both organizations are committed to the protection of human health, animal health, and the environment. This page lists announcements of funding opportunities intended to support the development of alternative test methods. If you are aware of a funding opportunity that could be included on this page, please contact NICEATM.

SBIR and STTR Omnibus Grant Solicitations of the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration

NIEHS is offering funding for small businesses developing technologies of interest to the Tox21 program. These technologies include:

  • Improved or expanded testing methods for toxicity screening
  • Computational approaches for predictive toxicology
  • Technologies such as alternative or improved methods for fixing and preserving tissues

The funding is being offered as part of the 2018 Omnibus Solicitation of the NIH, CDC, and Food and Drug Administration. This funding is available for small business grant applications to support development and commercialization of innovative technologies. View more information on the NIEHS website.

SBIR/STTR Omnibus Solicitations and Accompanying Resources

Next due date: January 5, 2019

For more information about this opportunity, contact:

NIH Funding Resources

The NIEHS SBIR/STTR Program Staff encourages applicants to submit grants at least one week before the deadline and to take advantage of the following resources:

PISC Offers Early-career Scientist Award to Attend IIVS Workshop

The PETA International Science Consortium (PISC) is sponsoring an award to attend a workshop on “Practical Methods for In Vitro Toxicology.” The workshop, offered by the Institute for In Vitro Sciences (IIVS), will be held on January 14-19, 2019, in Gaithersburg, Maryland. It will include lectures by experts in the field of in vitro toxicology and hands-on laboratory training on in vitro methods. Toxicological endpoints to be covered include skin and eye irritation and corrosion, skin sensitization, phototoxicity, and cytotoxicity. Attendees will gain a better understanding of in vitro methods, assay design, laboratory techniques, and data interpretation.

To be eligible for the PISC award, applicants must be current master’s or Ph.D. students who have completed their first year of study, postdoctoral fellows, or scientists who have completed a master’s, Ph.D., or postdoctoral appointment within the last three years. The award will cover the recipient’s registration costs and provide a travel stipend. The deadline for applying for the award is October 24. More information is available on the PISC website.

Funding Available for Tissue Chip Models

NIH and CDC are offering support to develop technologies and methodologies in the biomedical and behavioral sciences with potential to succeed as commercial products. As part of this opportunity, NCATS seeks proposals for novel media and materials to be used in microphysiological systems (MPS, or organs-on-chips). Applications are due October 22.

Proposals Invited for New Applications for In Vitro Respiratory Toxicity Systems

The PETA International Science Consortium and Epithelix seek proposals for applications for MucilAirTM or SmallAirTM three-dimensional reconstructed human respiratory tissues from Epithelix. The winning proposal will receive $5,000 redeemable for a MucilAir or SmallAir system. Proposals will be evaluated based on their scientific merit and potential to replace animal testing. Researchers from any sector and geographical region are encouraged to apply. Proposals are due October 31.